- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07944521
Avoidable Deaths After Non Traumatic Emergency General Surgery Registry (ANUBI)
Avoidable and Non-excludable Unexpected Deaths After Non Traumatic Emergency General Surgery Benchmarking Initiative
Background: Non traumatic Emergency general surgery disease are responsible for significant morbidity and mortality. In clinical practice a good number of deaths could probably be avoided. This may be related to delayed clinical decisions, imaging, or laboratory diagnostic inaccuracy. Objective: The ANUBI Registry aims to analyze avoidable deaths in non traumatic emergency general diseases evaluating all risk factors. Methods: ANUBI is a multicenter, prospective, registry carried out across multiple continents. Adult patients admitted and died for non traumatic emergency general surgery disease will be included. Data collection will be focused on all medical, surgical, radiologic, laboratory informations. Results The primary outcome is the incidence of avoidable death. Secondary outcomes include all possible factors affecting related decision-making and preventability of death. Conclusions: ANUBI aims globally assess preventable deaths in non traumatic emergency general surgery diseases analyzing potentially practice changing factors to patients' outcomes.
Study Overview
Status
Detailed Description
Urgent and emergent surgical interventions are complicated with high morbidity and mortality. Emergency surgery is one of the most challenging areas of surgery. Patients requiring acute care surgery interventions have advanced disease in the majority of cases, physiological derangement, and limited time for diagnosis and optimization. Thus morbidity and mortality rates are higher than elective surgery in spite of modern improvements in surgery, anesthesia and critical care. Many factors contribute to the poor outcomes in these patients: limited access to health care, delayed presentation, underestimation, and delayed diagnosis. Emergency surgical patients often present with sepsis, bleedings, shock, metabolic acidosis, coagulopathy, or hypothermia, which undermine the physiological reserve increasing morbidity and mortality. At the time of hospital admission this physiological derangement is already established which worsens overtime. All this is particularly amplified for special populations such as frails and/or elderly; there are even more vulnerable populations such as immunocompromised, pregnant, heart failure, respiratory insufficiency and anticoagulated patients. Acute care surgery procedures may have major complications, prolonged intensive care stay, and poor outcomes.
The urgent nature of these interventions limits opportunities for preoperative optimization and shared decision-making. Organizational factors play an important role: out-of-hours activity, lack of senior surgical expertise, lack of senior anesthesiology expertise, interventional radiology unavailability, lack of senior endoscopic expertise and intensive care resources paucity. All these factors are responsible of delayed/ineffective source control and poor perioperative care. Variability in protocols and experience are other significant contributors with different results among centers. Normally outcomes evaluation in emergency surgery is focused on mortality and morbidity, (M and M Meetings) without analyzing prevention and avoidability. There is a good evidence showing substantially that adverse outcomes are influenced by clinical, organizational, and decision-making factors. So it is important to identify these factors with accurate observational registries aiming to reduce preventable morbidity and mortality. In this setting, an accurate multicenter investigation on avoidable mortality in emergency general surgery is needed to improve perioperative strategies, and optimize patient safety. The ANUBI registry is the first multicenter registry that prospectively investigates fatal events following urgent surgical disease to analyze their potential avoidability using a structured evaluation.
Rationale
Emergency general surgery (non trauma) is a critical discipline in medicine responsible for a significant morbidity and mortality. In spite of improvements in surgery and perioperative care, mortality and morbidity rates remain higher compared with elective surgery. In most cases these adverse events occur in fragile patients caused by delayed diagnosis and/or inappropriate therapy. A hot issue for example is the identification of subjects who need second look after peritonitis or bowel ischemia. The decision making is based on clinical evaluation, imaging, laboratory tests which have low accuracy. The critical dilemma is always the same: delayed redo surgery and multi organ failure or unnecessary relaparotomy with additional morbidity and mortality. So, a significant number of deaths are avoidable with improvements in diagnosis and source control. We do not know the real incidence and risk factors of avoidable or probably avoidable deaths. There is no registry to identify and analyze these adverse events worldwide. The ANUBI Registry is designed to give specific answers on avoidable fatal events, focusing on possible determinants and quantifying the true incidence.
Moreover biomarkers (e.g. procalcitonin), imaging, and clinical scores will be analyzed for the influence on decision making.
A fundamental innovation of the ANUBI Registry is its global, prospective, observational approach across five continents. This analysis is going to investigate different clinical practices, resources, and decision-making strategies. It is aligned with precision surgery, tailored approach and value-based care. Avoiding death factors is a key strategy to reduce mortality and morbidity. This registry aims to transform reactive emergency surgery into an outcome-oriented emergency surgery.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Fausto Catena, Professor
- Phone Number: +393388560294
- Email: faustocatena@gmail.com
Study Contact Backup
- Name: Belinda De Simone, Dr
- Phone Number: +33665787872
- Email: desimone.belinda@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The study population will consist of consecutive adult patients (aged ≥18 years) admitted to participating hospitals with acute non-traumatic emergency general surgical conditions who undergo urgent or emergency surgical, therapeutic endoscopic, or interventional radiological procedures during the index hospitalization and die within 180 days of the index admission.
Patients will be identified across participating centers in different countries and healthcare settings, including emergency departments, surgical wards, operating rooms, and intensive care units.
Eligible cases will include deaths occurring during hospitalization, after discharge, or following transfer to another healthcare institution.
All eligible fatal events will be included regardless of their potential avoidability. Each case will undergo independent expert adjudication to assess the potential contribution of clinical, diagnostic, therapeutic, and organizational factors to death.
Description
Inclusion Criteria:
- Adult patients aged 18 years or older at the time of index hospital admission.
- Emergency hospital admission for an acute non-traumatic surgical condition requiring urgent or emergency management.
- Patients undergoing at least one non-elective surgical, therapeutic endoscopic, or interventional radiological procedure during the same hospital admission to treat the acute condition or its related complications.
- Qualifying procedures may be performed after initial resuscitation, physiological stabilization, or a period of non-operative management, including interventions performed more than 72 hours after hospital admission.
- Death from any cause occurring within 180 days of the index hospital admission, including in-hospital death, death after discharge, or death following transfer to another healthcare institution.
Exclusion Criteria:
- Patients younger than 18 years.
- Patients admitted for planned elective surgical procedures.
- Patients undergoing exclusively palliative surgical, endoscopic, or interventional radiological procedures.
- Patients managed exclusively through a comfort-only care pathway.
- Patients who do not undergo a qualifying surgical, therapeutic endoscopic, or interventional radiological procedure during the index hospital admission.
- Patients who do not die within 180 days of the index hospital admission.
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_ONLY
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
Fatal Events Following Non-Traumatic Emergency General Surgery
Adult patients (≥18 years) admitted for acute non-traumatic emergency general surgical conditions who undergo at least one non-elective surgical, therapeutic endoscopic, or interventional radiological procedure during the index hospitalization and die from any cause within 180 days of the index admission. Qualifying procedures may be performed after initial resuscitation, physiological stabilization, or a period of non-operative management. All eligible fatal events will be included regardless of their potential avoidability. Deaths will undergo independent expert adjudication to classify them as definitely avoidable, probably avoidable, or not avoidable. This is a non-interventional observational registry. All diagnostic and therapeutic decisions will follow routine clinical practice, without any study-assigned intervention. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Avoidable and Probably Avoidable Deaths Following Non-Traumatic Emergency General Surgery
Time Frame: From index hospital admission to death, up to 180 days
|
The primary outcome is the proportion of deaths classified as definitely avoidable or probably avoidable among all registered deaths following non-traumatic emergency general surgery conditions. Avoidability will be determined through blinded independent expert review using predefined clinical, diagnostic, therapeutic, and organizational criteria. The primary measure will be calculated as the number of definitely or probably avoidable deaths divided by the total number of registered deaths, multiplied by 100. |
From index hospital admission to death, up to 180 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timing and Distribution of Deaths
Time Frame: From index hospital admission to death, up to 180 days
|
Number and proportion of registered deaths occurring during the index hospitalization, within 30 days of index admission, and between days 31 and 180 after index admission. Time from admission to death will also be described. |
From index hospital admission to death, up to 180 days
|
|
Major Surgical Complications
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered patients with major surgical complications, including anastomotic leak, intra-abdominal abscess, postoperative bleeding, sepsis, and septic shock. Complications will be characterized using the Clavien-Dindo classification and the Comprehensive Complication Index, as applicable. |
From index admission to death, up to 180 days
|
|
Major Medical Complications and Organ Failure
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered patients experiencing respiratory failure requiring ventilatory support, acute kidney injury requiring renal replacement therapy, ischemic events, infections, or other organ failures. |
From index admission to death, up to 180 days
|
|
Unplanned Surgical, Endoscopic, and Radiological Reinterventions
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered patients undergoing unplanned reinterventions, including relaparotomy, relaparoscopy, interventional radiology, and therapeutic endoscopy. Reintervention types, indications, timing, and procedural findings will be described. |
From index admission to death, up to 180 days
|
|
Inadequate Source Control
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered patients with documented inadequate control of infection, bleeding, obstruction, or another acute surgical condition. The need for an additional surgical, endoscopic, or radiological intervention to achieve source control will be recorded. |
From index admission to death, up to 180 days
|
|
Diagnostic and Therapeutic Delays
Time Frame: From index admission to death, up to 180 days
|
Time intervals from hospital presentation to diagnosis, from hospital presentation to treatment decision, and from hospital presentation to initiation of definitive treatment or source control. Documented delays in imaging, transfer, treatment escalation, intensive care admission, and reintervention will also be assessed. |
From index admission to death, up to 180 days
|
|
Critical Care Utilization
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered patients requiring intensive or high-dependency care, unplanned ICU admission or readmission, unplanned intubation, vasopressor support, mechanical ventilation, or renal replacement therapy. Duration of organ support and ICU stay will be described. |
From index admission to death, up to 180 days
|
|
Failure to Rescue Following Major Complications
Time Frame: From index admission to death, up to 180 days
|
Number and proportion of registered deaths preceded by a documented major postoperative complication, with characterization of failure to recognize, escalate, or adequately manage the complication. This case-only assessment will not estimate the population-level failure-to-rescue rate. |
From index admission to death, up to 180 days
|
|
Clinical and Organizational Factors Contributing to Avoidable Death
Time Frame: At independent adjudication of deaths occurring within 180 days of index admission
|
Number and proportion of adjudicated cases in which independent reviewers identify diagnostic failures, therapeutic or technical failures, inadequate postoperative surveillance, communication failures, staffing limitations, resource constraints, or organizational delays as contributing factors to potentially avoidable death. |
At independent adjudication of deaths occurring within 180 days of index admission
|
|
Adherence to Recommended Perioperative Care
Time Frame: Perioperative/Periprocedural
|
Number and proportion of eligible registered cases with documented adherence to prespecified care processes, including timely antimicrobial prophylaxis or treatment, lactate and procalcitonin measurements, microbiological testing, thromboprophylaxis, respiratory support, and other relevant perioperative management measures. |
Perioperative/Periprocedural
|
|
Availability of Specialist Expertise and Emergency Care Resources
Time Frame: up to 180 days
|
Frequency of documented availability and involvement of senior surgical staff and relevant specialist teams, emergency operating rooms, intensive or high-dependency care, interventional radiology, and interventional endoscopy. Organizational characteristics will be evaluated in relation to death avoidability classification. |
up to 180 days
|
|
Total Hospital Length of Hospital (days)
Time Frame: From index hospital admission to discharge or in-hospital death (up to 180 days)
|
Total duration of hospitalization during the index admission, calculated from hospital admission to discharge or in-hospital death using hospital medical records. The outcome will be expressed in days. |
From index hospital admission to discharge or in-hospital death (up to 180 days)
|
|
Clinical Factors Associated With Death Avoidability
Time Frame: At independent adjudication of deaths occurring within 180 days of index admission
|
Associations between expert-adjudicated death avoidability and prespecified patient, clinical, physiological, treatment-related, and organizational variables, including age, frailty, comorbidity burden, septic shock, lactate, procalcitonin, treatment delays, consultant involvement, and hospital resources. |
At independent adjudication of deaths occurring within 180 days of index admission
|
|
Inter-Reviewer Agreement in Death Avoidability Assessment
Time Frame: At independent adjudication of deaths occurring within 180 days of index admission
|
Agreement among three independent expert reviewers regarding avoidability classification, assessed using percentage agreement and an appropriate kappa statistic. |
At independent adjudication of deaths occurring within 180 days of index admission
|
Collaborators and Investigators
Investigators
- Study Chair: Fausto Catena, Professor, World Society of Emergency Surgery-Institute for Research in Emergency General Surgery (WSES-IREGS)
- Principal Investigator: Belinda De Simone, MD, World Society of Emergency Surgery-Institute for Research in Emergency General Surgery (WSES-IREGS)
- Principal Investigator: Fikri Abu-Zidan, Professor, UAE University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Pathologic Processes
- Signs and Symptoms, Digestive
- Intestinal Diseases
- Infections
- Digestive System Diseases
- Gastrointestinal Diseases
- Systemic Inflammatory Response Syndrome
- Inflammation
- Abdominal Pain
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Sepsis
- Intraabdominal Infections
- Intestinal Obstruction
- Abdomen, Acute
Other Study ID Numbers
- WSES-ANUBI-2026-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.